Patents by Inventor David SKOLC

David SKOLC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Octahydroisoquinolinyl Derivatives
    Publication number: 20240043400
    Abstract: The present invention relates to octahydroisoquinolinyl derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: December 1, 2021
    Publication date: February 8, 2024
    Inventors: Ali Ates, Pierre Burssens, Adrian Hall, Laurent Provins, David Skolc, Anne Valade
  • A Substituted Tetrahydroisoquinoiline Derivative as a D1 Positive Allosteric Modulator
    Publication number: 20220259179
    Abstract: The present invention relates to compound according to formula (I), (I) which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: June 29, 2020
    Publication date: August 18, 2022
    Inventors: Ali Ates, David Skolc
  • Tetrahydroisoquinoline derivatives
    Patent number: 10105359
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 23, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Anne Valade, Eric Jnoff, Ali Ates, Pierre Burssens, David Skolc, Zara Sands, Benoit Mathieu
  • Isoindoline derivatives
    Patent number: 9975873
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Isoindoline Derivatives
    Publication number: 20170313677
    Abstract: The present invention relates to isoindoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: November 2, 2017
    Inventors: David Skolc, Ali Ates, Eric Jnoff, Anne Valade, Benoit Mathieu, Zara Sands
  • Tetrahydroisoquinoline Derivatives
    Publication number: 20170304292
    Abstract: The present invention relates to tetrahydroisoquinoline derivatives according to formula (I), which are Positive Allosteric Modulators of D1 and accordingly of benefit as pharmaceutical agents for the treatment of diseases in which D1 receptors play a role.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Anne VALADE, Eric JNOFF, Ali ATES, Pierre BURSSENS, David SKOLC, Zara SANDS, Benoit MATHIEU